We are live on ! Find out more
TOI icon

The Oncology Institute

108 hedge funds and large institutions have $121M invested in The Oncology Institute in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,185% more call options, than puts

Call options by funds: $3.55M | Put options by funds: $108K

483% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 6

85% more capital invested

Capital invested by funds: $65.5M → $121M (+$55.5M)

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

37% more funds holding

Funds holding: 79108 (+29)

2.33% more ownership

Funds ownership: 34.75%37.08% (+2.3%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
108
Holders Change
+29
Holders Change %
+36.71%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
35
Increased
33
Reduced
24
Closed
6
Calls
$3.55M
Puts
$108K
Net Calls
+$3.44M
Net Calls Change
+$3.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$15.9M +$906K +264,358 +6%
BlackRock
2
BlackRock
New York
$12M +$438K +127,971 +4%
DM
3
Deerfield Management
New York
$11.7M
CP
4
CenterBook Partners
Connecticut
$9.44M +$6.81M +1,988,751 +278%
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$8.79M
KWM
6
Kanen Wealth Management
Florida
$6.42M +$6.31M +1,842,101 New
WC
7
Wexford Capital
Florida
$5.48M +$1.55M +452,390 +40%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$4.89M +$420K +122,463 +10%
State Street
9
State Street
Massachusetts
$3.94M +$1.66M +483,768 +75%
UBS Group
10
UBS Group
Switzerland
$3.68M +$2.18M +635,489 +151%
Millennium Management
11
Millennium Management
New York
$3.32M +$1.87M +545,992 +135%
TAS
12
TIFF Advisory Services
Pennsylvania
$2.99M -$9.52M -2,777,837 -76%
BRF
13
B. Riley Financial
California
$2.83M +$1.2M +349,546 +76%
Renaissance Technologies
14
Renaissance Technologies
New York
$2.62M +$1M +293,000 +64%
Goldman Sachs
15
Goldman Sachs
New York
$2.38M +$1.81M +527,011 +341%
MHP
16
Manatuck Hill Partners
Connecticut
$2.2M +$1.3M +380,000 +152%
Northern Trust
17
Northern Trust
Illinois
$1.62M +$183K +53,335 +13%
MCM
18
Massar Capital Management
Connecticut
$1.4M
FCM
19
FourWorld Capital Management
New York
$1.25M -$115K -33,650 -9%
Two Sigma Investments
20
Two Sigma Investments
New York
$974K +$2.75K +802 +0.3%
LPL Financial
21
LPL Financial
California
$932K +$915K +266,985 New
BFM
22
Boothbay Fund Management
New York
$865K +$849K +247,884 New
EFI
23
EHP Funds Inc
Canada
$852K +$836K +244,041 New
FL
24
FreeGulliver LLC
Louisiana
$733K -$458K -133,800 -39%
JAIC
25
Josh Arnold Investment Consultant
Minnesota
$713K -$7.68M -2,242,300 -92%

TOI Hedge Fund Activity: Q3 2025 in Review

108 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q3 2025, worth a combined $121M — up 85% from $65.5M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new TOI positions and 6 closed out — a net gain of 29 holders — while 33 added to existing stakes and 24 trimmed.

The largest buyer was CenterBook Partners, adding an estimated $6.81M. The largest seller was TIFF Advisory Services, cutting an estimated $9.52M.

  • 108 institutional investors held The Oncology Institute (TOI) as of Q3 2025, up from 79 in Q2 2025.
  • Funds reported $121M of The Oncology Institute stock for Q3 2025, up 85% quarter-over-quarter.
  • 35 funds opened new The Oncology Institute positions in Q3 2025 and 6 closed out, a net change of +29 holders.
  • The largest The Oncology Institute buyer in Q3 2025 was CenterBook Partners, an estimated $6.81M added.
  • The largest The Oncology Institute seller in Q3 2025 was TIFF Advisory Services, an estimated $9.52M sold.

Based on aggregated 13F filings for Q3 2025.